Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00925132
Title Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Iowa
Indications

melanoma

Therapies

Decitabine + Panobinostat + Temozolomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.